Familial hypertrophic cardiomyopathy
MONDO:0024573Hypertrophic cardiomyopathy caused by mutations in the genes encoding components of the sarcomere, in the absence of predisposing conditions.
Also known as: cardiomyopathy, familial hypertrophic, familial hypertrophic cardiomyopathy, familila or idiopathic hypertrophic obstructive cardiomyopathy, hereditary hypertrophic cardiomyopathy, hypertrophic familial cardiomyopathy
94 clinical trials for this condition and its sub-types, 2 tagged with Familial hypertrophic cardiomyopathy itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Familial hypertrophic cardiomyopathy
-
Myotonic dystrophy type 1 45 trials
1 sub-type
-
Noonan syndrome and Noonan-related syndrome 1 trial · 29 incl. sub-types
6 sub-types
- Noonan syndrome 22 trials · 25 incl. sub-types Sub-types →
- Costello syndrome 7 trials
- Cardiofaciocutaneous syndrome 7 trials Sub-types →
- Legius syndrome 5 trials
- Noonan syndrome with multiple lentigines 3 trials Sub-types →
- Noonan syndrome-like disorder with loose anagen hair 0 trials Sub-types →
-
Beckwith-Wiedemann syndrome 6 trials
8 sub-types
- Beckwith-Wiedemann syndrome due to 11p15 microdeletion 0 trials
- Beckwith-Wiedemann syndrome due to 11p15 microduplication 0 trials
- Beckwith-Wiedemann syndrome due to 11p15 translocation/inversion 0 trials
- Beckwith-Wiedemann syndrome due to CDKN1C mutation 0 trials
- Beckwith-Wiedemann syndrome due to NSD1 mutation 0 trials
- Beckwith-Wiedemann syndrome due to imprinting defect of 11p15 0 trials
- Beckwith-Wiedemann syndrome due to paternal uniparental disomy of chromosome 11 0 trials
- Franceschini Vardeu Guala syndrome 0 trials
-
Dilated cardiomyopathy 1C 1 trial
-
5 sub-types
- Glutaric acidemia IIa 0 trials
- Glutaric acidemia IIb 0 trials
- Glutaric acidemia IIc 0 trials
- Multiple acyl-CoA dehydrogenase deficiency, mild type 0 trials
- Multiple acyl-CoA dehydrogenase deficiency, severe neonatal type 0 trials
-
46,XY complete gonadal dysgenesis 0 trials · 1 incl. sub-types
12 sub-types
- 46,XY sex reversal 5 1 trial
- 46,XY disorder of sex development due to testicular 17,20-desmolase deficiency 0 trials
- 46,XY gonadal dysgenesis-motor and sensory neuropathy syndrome 0 trials
- 46,XY sex reversal 1 0 trials
- 46,XY sex reversal 10 0 trials
- 46,XY sex reversal 11 0 trials
- 46,XY sex reversal 2 0 trials
- 46,XY sex reversal 3 0 trials
- 46,XY sex reversal 4 0 trials
- 46,XY sex reversal 6 0 trials
- 46,XY sex reversal 7 0 trials
- 46,XY sex reversal 9 0 trials
-
Dilated cardiomyopathy 1KK 0 trials
-
Hypertrophic cardiomyopathy 1 0 trials
-
Hypertrophic cardiomyopathy 10 0 trials
-
Hypertrophic cardiomyopathy 11 0 trials
-
Hypertrophic cardiomyopathy 12 0 trials
-
Hypertrophic cardiomyopathy 13 0 trials
-
Hypertrophic cardiomyopathy 14 0 trials
-
Hypertrophic cardiomyopathy 15 0 trials
-
Hypertrophic cardiomyopathy 16 0 trials
-
Hypertrophic cardiomyopathy 17 0 trials
-
Hypertrophic cardiomyopathy 18 0 trials
-
Hypertrophic cardiomyopathy 19 0 trials
-
Hypertrophic cardiomyopathy 2 0 trials
-
Hypertrophic cardiomyopathy 20 0 trials
-
Hypertrophic cardiomyopathy 21 0 trials
-
Hypertrophic cardiomyopathy 25 0 trials
-
Hypertrophic cardiomyopathy 26 0 trials
-
Hypertrophic cardiomyopathy 3 0 trials
-
Hypertrophic cardiomyopathy 4 0 trials
-
Hypertrophic cardiomyopathy 6 0 trials
-
Hypertrophic cardiomyopathy 7 0 trials
-
Hypertrophic cardiomyopathy 8 0 trials
-
Hypertrophic cardiomyopathy 9 0 trials
Most studied deeper sub-types
-
Cancer drug tested against deadly infant heart disease
Disease control Not yet recruitingResearchers are testing whether trametinib, an FDA-approved cancer drug, can help infants with RASopathies who have a severe, life-threatening heart condition called hypertrophic cardiomyopathy. The trial enrolls about 25 babies with a confirmed genetic diagnosis. Participants re…
Phase 3 • Sponsor: Carelon Research • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Can a simple muscle exercise improve erectile function in men with low testosterone?
Disease control Not yet recruitingThis study tests whether pelvic floor muscle training (PFMT) with a handheld biofeedback device can improve erectile function and sexual quality of life in men with functional hypogonadism (low testosterone) and erectile dysfunction. Participants are randomly assigned to PFMT wit…
Sponsor: Poznan University of Physical Education • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Could a common blood pressure pill ease muscle stiffness? early trial launches
Symptom relief Not yet recruitingThis early-stage trial tests amlodipine, a calcium channel blocker used for high blood pressure, in 20 adults with myotonic dystrophy type 1. The goal is to see if the drug is safe and can improve muscle strength, reduce stiffness, and help with daily function. All participants w…
Phase 1 • Sponsor: University of Rochester • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
Could you help scientists unlock genetic cancer secrets?
Knowledge-focused Not yet recruitingThis study screens up to 1,000 people with personal or family histories of certain cancers to see if they qualify for ongoing genetics research at the National Cancer Institute. Participants fill out a 15-20 minute online survey about their health and family history. No treatment…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 21, 2026 21:00 UTC
-
Can watching the course of myotonic dystrophy unlock better care?
Knowledge-focused Not yet recruitingThis study follows 100 adults with myotonic dystrophy (types 1 or 2) for two years to understand how muscle stiffness, daily function, and heart health change over time. Researchers will look back at up to 18 months of past medical records and then track participants with clinic …
Sponsor: Lupin Ltd. • Aim: Knowledge-focused
Last updated Jul 30, 2026 00:00 UTC
-
Scientists investigate hidden genetic patterns in rare childhood disorders
Knowledge-focused Not yet recruitingThis study aims to better understand a condition called multilocus imprinting disorder (MLID), where multiple genes are affected by abnormal chemical marks. Researchers will test a new technique to detect these marks in 96 people, including those with known imprinting disorders a…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
New study aims to predict bleeding dangers in noonan syndrome patients
Knowledge-focused Not yet recruitingThis study looks at why people with Noonan syndrome often bleed easily, especially from the skin, mouth, or nose. Researchers will compare a simple questionnaire about bleeding history with blood tests in 100 patients. The goal is to find better ways to predict serious bleeding, …
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC